The DOI matches its Crossref record; 168 of the 169 references it cites were found in a registry or an index.
The first 30 years of p53: growing ever more complex.
Open accessAbstract
Thirty years ago p53 was discovered as a cellular partner of simian virus 40 large T-antigen, the oncoprotein of this tumour virus. The first decade of p53 research saw the cloning of p53 DNA and the realization that p53 is not an oncogene but a tumour suppressor that is very frequently mutated in human cancer. In the second decade of research, the function of p53 was uncovered: it is a transcription factor induced by stress, which can promote cell cycle arrest, apoptosis and senescence. In the third decade after its discovery new functions of this protein were revealed, including the regulation of metabolic pathways and cytokines that are required for embryo implantation. The fourth decade of research may see new p53-based drugs to treat cancer. What is next is anybody's guess.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both these pathways are complex as they involve many upstream regulators and downstream effectors along with varying side branches (Chau and Wang, 2003; Levine and Oren, 2009).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Levine and Oren, 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“More recently, induction of cellular senescence was identified as an additional mechanism whereby p53 curbs neoplastic processe”
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Self-citationTumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Self-citationGerm Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Flagged first, then by citations
1 of the 169 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 801–900 of 1,002
Banerjee, S., Tsutsui, K., & Chaturvedi, C. M. (2016) · Journal of Experimental Biology · doi:10.1242/jeb.129155 · Cited by 23
VOLIN and KJON—Two novel hyperdiploid myeloma cell lines
Våtsveen, T. K., Børset, M., Dikic, A., Tian, E., Micci, F., Lid, A. H. B., Meza‐Zepeda, L. A., Coward, E., Waage, A., Sundan, A., et al. (2016) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22388 · Cited by 23
Association between polymorphisms in TP53 and MDM2 genes and susceptibility to prostate cancer
Hashemi, M. M., Amininia, S., Ebrahimi, M., Simforoosh, N., Basiri, A., Ziaee, S. A. M., Narouie, B., Sotoudeh, M., Mollakouchekian, M. J., Maleki, E. R., et al. (2017) · Oncology Letters · doi:10.3892/ol.2017.5739 · Cited by 23
An integrated method for the identification of novel genes related to oral cancer
Chen, L., Yang, J., Xing, Z., Yuan, F., Shu, Y., Zhang, Y., Kong, X., Huang, T., Li, H., & Cai, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175185 · Cited by 23
Krüppel-Like Factor 6 Is Required for Oxidative and Oncogene-Induced Cellular Senescence
Sabatino, M. E., Castellaro, A., Racca, A. C., Carbajosa González, S., Pansa, M. F., Soria, G., & Bocco, J. L. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00297 · Cited by 23
Gintoni, I., Vassiliou, S., Chrousos, G. P., & Yapijakis, C. (2023) · Genes · doi:10.3390/genes14081578 · Cited by 23
Structural basis of how stress-induced MDMX phosphorylation activates p53
Chen, X., Gohain, N., Zhan, C., Lu, W.-Y., Pazgier, M., & Lu, W. (2015) · Oncogene · doi:10.1038/onc.2015.255 · Cited by 22
Leandro, G. D. S., Lôbo, R. R., Oliveira, D. V. N. P., Moriguti, J. C., & Sakamoto‐Hojo, E. T. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140612380 · Cited by 23
Cell Context Dependent p53 Genome-Wide Binding Patterns and Enrichment at Repeats
Botcheva, K., & McCorkle, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113492 · Cited by 23
Yang, M., Yuan, F., Li, P., Chen, Z., Chen, A., Li, S., & Hu, C. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-54 · Cited by 23
The mutational status of p53 can influence its recognition by human T-cells
Shamalov, K., Levy, S. N., Horovitz‐Fried, M., & Cohen, C. J. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1285990 · Cited by 23
Iscador Qu inhibits doxorubicin-induced senescence of MCF7 cells
Srdić‐Rajić, T., Santibanez, J. F., Kanjer, K., Miletić, N. T., Cavic, M. R., Galun, D., Jevric, M., Kardum, N., Konić‐Ristić, A., & Zoranovic, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-03898-0 · Cited by 23
Long noncoding RNA s: A new player in the prevention and treatment of diabetic cardiomyopathy?
Ma, C., Luo, H., Liu, B., Li, F., Tschöpe, C., & Fa, X. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3056 · Cited by 22
Characterizing Cancer Drug Response and Biological Correlates: A Geometric Network Approach
Pouryahya, M., Oh, J. H., Mathews, J. C., Deasy, J. O., & Tannenbaum, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-24679-3 · Cited by 23
p53: An Attractive Therapeutic Target for Cancer
Patel, K. R., & Patel, H. D. (2019) · Current Medicinal Chemistry · doi:10.2174/1573406415666190621094704 · Cited by 24
Liu, H., Liu, Z., Lu, T., Zhang, L., Cheng, J., Fu, X., & Hou, Y. (2019) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2019.06.006 · Cited by 23
Zhang, L., Yan, B., Meng, S., Zhou, L., Xu, Y., Du, W., & Shan, L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01317 · Cited by 23
Crosstalk Between Vitamin D and p53 Signaling in Cancer: An Update
Reichrath, J., Reichrath, S., VOGT, T. M., & Römer, K. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-46227-7_15 · Cited by 23
Viral Infections: Negative Regulators of Apoptosis and Oncogenic Factors
Zamaraev, A. V., Zhivotovsky, B., & Kopeina, G. S. (2020) · Biochemistry (Moscow) · doi:10.1134/s0006297920100077 · Cited by 22
The can and can’t dos of p53 RNA
Candeias, M. M. (2011) · Biochimie · doi:10.1016/j.biochi.2011.06.010 · Cited by 23
Wang, X., Yan, Z., Fulciniti, M., Li, Y., Gkotzamanidou, M. A., Amin, S. B., Shah, P. K., Zhang, Y., Munshi, N. C., & Li, C. (2013) · Leukemia · doi:10.1038/leu.2013.233 · Cited by 24
Velalopoulou, A., Chatterjee, S., Pietrofesa, R., Koziol-White, C., Panettieri, R., Lin, L., Tuttle, S., Berman, A., Koumenis, C., & Christofidou-Solomidou, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122525 · Cited by 22
Michaeli, O., Luz, I., Vatarescu, M., Manko, T., Weizman, N., Korotinsky, Y., Tsitrina, A. A., Braiman, A., Arazi, L., & Cooks, T. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06830-3 · Cited by 23
Fu, S., Yang, Y., Liu, D., Luo, Y., Ye, X., Liu, Y., Chen, X., Wang, S., Wu, H., Wang, Y., et al. (2017) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x17500239 · Cited by 22
Hohensinner, P. J., Takács, N. M., Kaun, C., Thaler, B., Krychtiuk, K. A., Pfaffenberger, S., Aliabadi, A. Z., Zuckermann, A. O., Huber, K., & Wojta, J. (2017) · APOPTOSIS · doi:10.1007/s10495-017-1388-9 · Cited by 22
Smith, A. J., & Smith, L. A. (2016) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.09.007 · Cited by 23
Li, Q., Hao, Q., Cao, W., Li, J., Wu, K., Elshimali, Y., Zhu, D., Chen, Q., Chen, G., Pollack, J. R., et al. (2019) · Science Advances · doi:10.1126/sciadv.aaw8417 · Cited by 23
Ahmed, C. M. S., Cui, Y., Frie, A. L., Burr, A. C., Kamath, R., Chen, J. Y., Rahman, A., Nordgren, T. M., Lin, Y., & Bahreini, R. (2019) · Environmental Science & Technology · doi:10.1021/acs.est.9b04376 · Cited by 22
Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma
Maturo, M. G., Rachakonda, P. S., Heidenreich, B., Pellegrini, C., Srinivas, N., Requena, C., Serra-Guillén, C., Llombart, B., Sanmartín, O., Guillén, C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-65057-2 · Cited by 22
Cryptic amyloidogenic regions in intrinsically disordered proteins: Function and disease association
Santos, J., Pallarès, I., Iglesias, V., & Ventura, S. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.07.019 · Cited by 22
Developmental Acquisition of p53 Functions
Jaiswal, S. K., Raj, S., & Depamphilis, M. (2021) · Genes · doi:10.3390/genes12111675 · Cited by 23
Disruption of the mevalonate pathway induces dNTP depletion and DNA damage
Martín-Sánchez, C., Martín, J. M. P., Jin, J., Dávalos, A., Zhang, W., de la Peña, G., Martı́nez-Botas, J., Rodríguez‐Acebes, S., Suárez, Y., Hazen, M. J., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.06.001 · Cited by 22
PDCD5 functions as a regulator of p53 dynamics in the DNA damage response
Zhuge, C., Sun, X., Chen, Y., & Lei, J. (2015) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2015.09.025 · Cited by 23
The emerging role of Mule and ARF in the regulation of base excision repair
Khoronenkova, S. V., & Dianov, G. L. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.06.015 · Cited by 23
p53 restoration kills primitive leukemia cells in vivo and increases survival of leukemic mice
Velasco-Hernández, T., Vicente‐Dueñas, C., Sánchez-Garcı́a, I., & Martı́n-Zanca, D. (2012) · Cell Cycle · doi:10.4161/cc.23031 · Cited by 23
p53 immunohistochemical expression and patient prognosis in esophageal squamous cell carcinoma
Murata, A., Baba, Y., Watanabe, M., Shigaki, H., Miyake, K., Karashima, R., Imamura, Y., Ida, S., Ishimoto, T., Iwagami, S., et al. (2013) · Medical Oncology · doi:10.1007/s12032-013-0728-z · Cited by 22
Zong, J.-F., Wang, D., Jiao, W., Zhang, L., Bao, G., Ho, C., Hou, R., & Wan, X. (2016) · RSC Advances · doi:10.1039/c6ra14467e · Cited by 22
Qiang, W., Sui, F., Ma, J., Li, X., Ren, X., Shao, Y., Liu, J., Guan, H., Shi, B., & Hou, P. (2017) · Endocrine · doi:10.1007/s12020-017-1256-y · Cited by 23
Cubillos‐Rojas, M., Schneider, T., Bartrons, R., Ventura, F., & Rosa, J. L. (2017) · Oncotarget · doi:10.18632/oncotarget.18699 · Cited by 22
Carroll, B. L., Bonica, J., Shamseddine, A. A., Hannun, Y. A., & Obeid, L. M. (2017) · FEBS Open Bio · doi:10.1002/2211-5463.12344 · Cited by 22
Singamsetty, G. K., Malempati, S., Bhogadhi, S., Kondreddy, R., Govatati, S., Tangudu, N. K., Govatati, S., kuraganti, A. K., Bhanoori, M., & Kassetty, K. (2013) · Tumor Biology · doi:10.1007/s13277-013-1305-y · Cited by 22
Human pancreatic cancer progression: an anarchy among CCN-siblings
Banerjee, S. K., Maity, G., Haque, I., Ghosh, A., Sarkar, S., Gupta, V. G., Campbell, D. R., Hoff, D. D. V., & Banerjee, S. (2016) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-016-0343-9 · Cited by 21
Downregulation of cyclin D1 sensitizes cancer cells to MDM2 antagonist Nutlin-3
Yang, P., Chen, W., Li, X., Eilers, G., He, Q., Liu, L., Wu, Y., Wu, Y., Yu, W., Fletcher, J. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8999 · Cited by 21
Strategies for p53 Activation and Targeted Inhibitors of the p53-Mdm2/MdmX Interaction
Huang, Y., Wang, L., Zhou, Y., Bai, J., Li, N., Su, Z., & Cheng, X. (2025) · Cells · doi:10.3390/cells14080583 · Cited by 25
Neurodegeneration rewires the tumor microenvironment via the neuro–immune–cancer axis
Bautista, J., Coral-Riofrio, E. C., Urresta, S. S., Palacios-Zavala, D., Echeverría, C. E., Araujo‐Abad, S., & López‐Cortés, A. (2025) · iScience · doi:10.1016/j.isci.2025.113550 · Cited by 22
Novel p53 target genes secreted by the liver are involved in non-cell-autonomous regulation
Charni, M., Molchadsky, A., Goldstein, I., Solomon, H., Tal, P., Goldfinger, N., Yang, P., Porat, Z., Lozano, G., & Rotter, V. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.119 · Cited by 21
Molecular Pathogenesis and Current Therapy in Intrahepatic Cholangiocarcinoma
Høgdall, D., O’Rourke, C. J., Taranta, A., Oliveira, D. V. N. P., & Andersen, J. B. (2016) · Digestive Diseases · doi:10.1159/000444562 · Cited by 21
Y-box Binding Protein 1: Looking Back to the Future
Evdokimova, V. E. (2022) · Biochemistry (Moscow) · doi:10.1134/s0006297922140024 · Cited by 22
Khaniki, S. H., Shokoohi, F., Esmaily, H., & Kerachian, M. A. (2023) · Scientific Reports · doi:10.1038/s41598-023-47377-1 · Cited by 23
Jansen, J., Bohnsack, K. E., Böhlken-Fascher, S., Bohnsack, M. T., & Dobbelstein, M. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114610 · Cited by 21
RNF125 is a Ubiquitin-Protein Ligase that Promotes p53 Degradation
Yang, L., Zhou, B., Li, X., Lu, Z., Li, W., Huo, X., & Miao, Z. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000369691 · Cited by 21
Yu, Z., Wu, F., Chen, L., Li, Q., Wang, C., Dong, J., & Xie, S. (2014) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2014.10.001 · Cited by 21
Cell fate conversion: Direct induction of hepatocyte‐like cells from fibroblasts
Ji, S., Zhang, L., & Hui, L. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24380 · Cited by 21
Chen, B., Wang, J., & Xia, G. (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s14957 · Cited by 21
Halaby, M., Hakem, A., Li, L., Ghamrasni, S. E., Venkatesan, S., Hande, M. P., Sanchez, O. H., & Hakem, R. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003259 · Cited by 21
Sohr, S., & Engeland, K. (2011) · Cell Cycle · doi:10.4161/cc.10.21.17946 · Cited by 22
Impact of Cellular Senescence in Aging and Cancer
Provinciali, M., Cardelli, M., Marchegiani, F., & Pierpaoli, E. (2013) · Current Pharmaceutical Design · doi:10.2174/138161213805219739 · Cited by 21
Lessons from interconnected ubiquitylation and acetylation of p53: think metastable networks
Benkirane, M., Sardet, C., & Coux, O. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380098 · Cited by 24
Solution structure and binding specificity of the p63 DNA binding domain
Enthart, A., Klein, C., Dehner, A., Coles, M. P., Gemmecker, G., Kessler, H., & Hagn, F. (2016) · Scientific Reports · doi:10.1038/srep26707 · Cited by 21
Tebufenozide induces G1/S cell cycle arrest and apoptosis in human cells
Xu, W., Wang, B., Yang, M., Zhang, Y., Xu, Z., Yang, Y., Cao, H., & Tao, L. (2016) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2016.12.002 · Cited by 21
Deng, F., Li, M., Shan, W., Qian, L.-T., Meng, S.-P., Zhang, X., & Wang, B. (2017) · Oncology Letters · doi:10.3892/ol.2017.5711 · Cited by 21
Witt, K. L., Hsieh, J., Smith‐Roe, S. L., Xia, M., Huang, R., Zhao, J., Auerbach, S. S., Hur, J., & Tice, R. R. (2017) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22112 · Cited by 21
Tao, H., Xiong, Q., Ji, Z., Zhang, F., Liu, Y., & Chen, M. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.29273 · Cited by 21
P53 and Apoptosis in the Drosophila Model
Zhou, L. J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-23629-8_6 · Cited by 20
Halver, J., Wenzel, K., Sendker, J., García, C. C., Erdelmeier, C. A. J., Willems, E., Mercola, M. A., Symma, N., Könemann, S., Koch, E., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01357 · Cited by 21
The foundational framework of tumors: Gametogenesis, p53, and cancer
Liu, C., Moten, A., Ma, Z., & Lin, H. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.04.018 · Cited by 21
Tesfaye, E., Martínez‐Terroba, E., Bendor, J., Winkler, L., Olivero, C. E., Chen, K., Feldser, D. M., Zamudio, J. R., & Dimitrova, N. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025539118 · Cited by 21
The tissue dependent interactions between p53 and Bcl-2 in vivo
Li, X., Miao, X., Wang, H., Xu, Z., & Ли, Б. (2015) · Oncotarget · doi:10.18632/oncotarget.5372 · Cited by 20
Connections between 3′ end processing and DNA damage response: Ten years later
Murphy, M. R., & Kleiman, F. E. (2019) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1571 · Cited by 21
Protecting the genome from mdm2 and mdmx
Melo, A. N., & Eischen, C. M. (2012) · Genes & Cancer · doi:10.1177/1947601912454139 · Cited by 20
Zampini, M., Riva, E., Lanino, L., Sauta, E., Reis, R. A. D., Ejarque, R. A., Maggioni, G., Termanini, A., Merlotti, A., Campagna, A., et al. (2025) · Journal of Clinical Oncology · doi:10.1200/jco-24-02394 · Cited by 21
Brázda, V., Čechová, J., Battistin, M., Coufal, J., Jagelská, E. B., Raimondi, I., & Inga, A. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.113 · Cited by 20
Kim, Y. M., Ko, S., Shin, Y., Kim, Y., Kim, T. P., Jung, J., Lee, S., Kim, N. G., Park, K., & Ryu, J. H. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29943 · Cited by 20
Centromere protein N may be a novel malignant prognostic biomarker for hepatocellular carcinoma
Wang, Q., Yu, X., Zheng, Z., Chen, F., Yang, N., & Zhou, Y. (2021) · PeerJ · doi:10.7717/peerj.11342 · Cited by 20
Koike, K., Masuda, T., Sato, K., Fujii, A., Wakiyama, H., Tobo, T., Takahashi, J., Motomura, Y., Nakano, T., Saito, H., et al. (2021) · Cancer Science · doi:10.1111/cas.15174 · Cited by 18
Biomarkers in the Occurrence and Development of Pterygium
He, S., & Wu, Z. (2022) · Ophthalmic Research · doi:10.1159/000523878 · Cited by 23
Huang, L., Li, J., Yang, J., Zhang, X., Zhang, X., He, J., Zhang, G., Li, W., Wang, H., Li, J., et al. (2022) · Cells · doi:10.3390/cells11244085 · Cited by 20
NAD+ Metabolism in Age-Related Hearing Loss
Kim, H. (2014) · Aging and Disease · doi:10.14336/ad.2014.0500150 · Cited by 20
Polonio-Vallon, T., Krüger, D., & Hofmann, T. G. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00148 · Cited by 23
Zhao, L., Zhao, X., Wu, X., & Tang, W. (2013) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2013.0103 · Cited by 20
Checler, F., & da Costa, C. A. (2013) · Neurodegenerative Diseases · doi:10.1159/000354075 · Cited by 20
Li, L., Xu, Y., & Wang, B. (2014) · Oncology Letters · doi:10.3892/ol.2014.2834 · Cited by 20
RetractedLincRNAs and base modifications of p53 induced by arsenic methylation in workers
Wen, W., Lü, L., He, Y., Cheng, H., He, F., Cao, S., Li, L., Li, X., & Wu, T. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.01.003 · Cited by 20
Nakamura, M., Sugimoto, H., Ogata, T., Hiraoka, K., Yoda, H., Sang, M., Sang, M., Zhu, Y., Yu, M., Shimozato, O., et al. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.40 · Cited by 19
Identification and characterization of a metastatic suppressor BRMS 1L as a target gene of p53
Koyama, R., Tamura, M., Nakagaki, T., Ohashi, T., Idogawa, M., Suzuki, H., Tokino, T., & Sasaki, Y. (2017) · Cancer Science · doi:10.1111/cas.13420 · Cited by 20
Genome‐scale analysis to identify prognostic markers and predict the survival of lung adenocarcinoma
Li, Y., Yang, C., Zhou, P., Zhang, S., Yao Zong, Y. U. A. N., & Li, D. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27144 · Cited by 20
Li, X., Wu, L., Zopp, M., Kopelov, S., & Du, W. (2019) · Stem Cells · doi:10.1002/stem.3015 · Cited by 20
Orellana, E. A., Li, C., Lisevick, A. B., & Kasinski, A. L. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1634956 · Cited by 20
p53 dynamics in single cells are temperature-sensitive
Jentsch, M., Snyder, P., Sheng, C., Cristiano, E., & Loewer, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-58267-1 · Cited by 20
Network hub-node prioritization of gene regulation with intra-network association
Chang, H.-C., Chu, C.-P., Lin, S.-J., & Hsiao, C. K. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-3444-7 · Cited by 20
Chen, W., Chen, M., Zhao, Z., Weng, Q., Song, J., Fang, S., Wu, X., Wang, H., Zhang, D., Yang, W., et al. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00126 · Cited by 20
Retractedp53 Activation in Genetic Disorders: Different Routes to the Same Destination
Tsai, Y.-Y., Su, C.-H., & Tarn, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179307 · Cited by 21
Pronsato, L., Milanesi, L. M., Vasconsuelo, A., & la Colla, A. B. (2017) · Steroids · doi:10.1016/j.steroids.2017.05.012 · Cited by 20
Genomics of aggressive B-cell lymphoma
Rosenthal, A. C., & Rimsza, L. M. (2018) · Hematology · doi:10.1182/asheducation-2018.1.69 · Cited by 20
Notch and the p53 Clan of Transcription Factors
Roemer, K. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0899-4_17 · Cited by 20
Myelodysplasia Syndrome, Clonal Hematopoiesis and Cardiovascular Disease
Veiga, C. B., Lawrence, E., Murphy, A. J., Herold, M. J., & Dragoljevic, D. (2021) · Cancers · doi:10.3390/cancers13081968 · Cited by 20
Dorandish, S., Atali, S., Ray, R., Khashali, H. A., Coleman, K.-L., Guthrie, J. W., Heyl, D., & Evans, H. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137059 · Cited by 19
Liu, Y., Hua, Q., Li, M., Li, X., Chen, W., Zeng, H., Diao, Q., Shi, C., Ling, Y., & Jiang, Y. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03297-z · Cited by 19
Circular RNAs play roles in regulatory networks of cell signaling pathways in human cancers
Almouh, M., Razmara, E., Bitaraf, A., Ghazimoradi, M. H., Hassan, Z. M., & Babashah, S. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120975 · Cited by 19
Coleman, K.-L., Chiaramonti, M., Haddad, B., Ranzenberger, R., Henning, H., Khashali, H. A., Ray, R., Darweesh, B., Guthrie, J. W., Heyl, D., et al. (2023) · Cells · doi:10.3390/cells12030405 · Cited by 19
Metadata
- Authors
- Levine, A. J., & Oren, M.
- Affiliations
- Institute for Advanced Study (US)
- Weizmann Institute of Science (IL)
- Venue
- Nature Reviews Cancer
- Published
- 2009-10
- Volume
- 9
- Issue
- 10
- Pages
- 749-758
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC2771725
- OpenAlex
- W1966163762
- Cited by
- 1,967
- References
- 169
- Citations by year
- 2026: 64 · 2025: 111 · 2024: 107 · 2023: 112 · 2022: 114 · 2021: 129 · 2020: 128 · 2019: 111 · 2018: 127 · 2017: 120 · 2016: 144 · 2015: 115 · 2014: 150 · 2013: 113 · 2012: 170
- FWCI
- 9.34
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (P01CA087497, R37 CA40099, R37CA040099, P01CA87497.)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- p53, TP53, tumour suppressor, SV40 large T antigen, transcription factors, cell cycle arrest, apoptosis, cellular senescence, metabolic regulation, cytokine regulation, embryo implantation
- MeSH terms
- Animals, Humans, Neoplasms, Genes, p53, Tumor Suppressor Protein p53, History, 20th Century, History, 21st Century
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review